Cargando…
Meeting people where they are: implementing hospital-based substance use harm reduction
BACKGROUND: Hospital-based addiction care focuses on assessing and diagnosing substance use disorders, managing withdrawal, and initiating medications for addiction treatment. Hospital harm reduction is generally limited to prescribing naloxone. Hospitals can better serve individuals with substance...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8826677/ https://www.ncbi.nlm.nih.gov/pubmed/35139877 http://dx.doi.org/10.1186/s12954-022-00594-9 |
_version_ | 1784647476819525632 |
---|---|
author | Perera, Rachel Stephan, Louise Appa, Ayesha Giuliano, Ro Hoffman, Robert Lum, Paula Martin, Marlene |
author_facet | Perera, Rachel Stephan, Louise Appa, Ayesha Giuliano, Ro Hoffman, Robert Lum, Paula Martin, Marlene |
author_sort | Perera, Rachel |
collection | PubMed |
description | BACKGROUND: Hospital-based addiction care focuses on assessing and diagnosing substance use disorders, managing withdrawal, and initiating medications for addiction treatment. Hospital harm reduction is generally limited to prescribing naloxone. Hospitals can better serve individuals with substance use disorders by incorporating harm reduction education and equipment provision as essential addiction care. We describe the implementation of a hospital intervention that provides harm reduction education and equipment (e.g., syringes, pipes, and fentanyl test strips) to patients via an addiction consult team in an urban, safety-net hospital. METHODS: We performed a needs assessment to determine patient harm reduction needs. We partnered with a community-based organization who provided us harm reduction equipment and training. We engaged executive, regulatory, and nursing leadership to obtain support. After ensuring regulatory compliance, training our team, and developing a workflow, we implemented this harm reduction program that provides education and equipment to individuals whose substance use goals do not include abstinence. RESULTS: During a 12-month period we provided 195 individuals harm reduction kits. CONCLUSIONS: This intervention allowed us to advance hospital-based addiction care, better educate and engage patients, staff, and clinicians, and reduce stigma. By establishing a community harm reduction partner, obtaining support from hospital leadership, and incorporating feedback from staff, clinicians, and patients, we successfully implemented harm reduction education and equipment provision in a hospital setting as part of evidence-based addiction care. Trial registration: Commentary, none. |
format | Online Article Text |
id | pubmed-8826677 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-88266772022-02-10 Meeting people where they are: implementing hospital-based substance use harm reduction Perera, Rachel Stephan, Louise Appa, Ayesha Giuliano, Ro Hoffman, Robert Lum, Paula Martin, Marlene Harm Reduct J Commentary BACKGROUND: Hospital-based addiction care focuses on assessing and diagnosing substance use disorders, managing withdrawal, and initiating medications for addiction treatment. Hospital harm reduction is generally limited to prescribing naloxone. Hospitals can better serve individuals with substance use disorders by incorporating harm reduction education and equipment provision as essential addiction care. We describe the implementation of a hospital intervention that provides harm reduction education and equipment (e.g., syringes, pipes, and fentanyl test strips) to patients via an addiction consult team in an urban, safety-net hospital. METHODS: We performed a needs assessment to determine patient harm reduction needs. We partnered with a community-based organization who provided us harm reduction equipment and training. We engaged executive, regulatory, and nursing leadership to obtain support. After ensuring regulatory compliance, training our team, and developing a workflow, we implemented this harm reduction program that provides education and equipment to individuals whose substance use goals do not include abstinence. RESULTS: During a 12-month period we provided 195 individuals harm reduction kits. CONCLUSIONS: This intervention allowed us to advance hospital-based addiction care, better educate and engage patients, staff, and clinicians, and reduce stigma. By establishing a community harm reduction partner, obtaining support from hospital leadership, and incorporating feedback from staff, clinicians, and patients, we successfully implemented harm reduction education and equipment provision in a hospital setting as part of evidence-based addiction care. Trial registration: Commentary, none. BioMed Central 2022-02-09 /pmc/articles/PMC8826677/ /pubmed/35139877 http://dx.doi.org/10.1186/s12954-022-00594-9 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Commentary Perera, Rachel Stephan, Louise Appa, Ayesha Giuliano, Ro Hoffman, Robert Lum, Paula Martin, Marlene Meeting people where they are: implementing hospital-based substance use harm reduction |
title | Meeting people where they are: implementing hospital-based substance use harm reduction |
title_full | Meeting people where they are: implementing hospital-based substance use harm reduction |
title_fullStr | Meeting people where they are: implementing hospital-based substance use harm reduction |
title_full_unstemmed | Meeting people where they are: implementing hospital-based substance use harm reduction |
title_short | Meeting people where they are: implementing hospital-based substance use harm reduction |
title_sort | meeting people where they are: implementing hospital-based substance use harm reduction |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8826677/ https://www.ncbi.nlm.nih.gov/pubmed/35139877 http://dx.doi.org/10.1186/s12954-022-00594-9 |
work_keys_str_mv | AT pererarachel meetingpeoplewheretheyareimplementinghospitalbasedsubstanceuseharmreduction AT stephanlouise meetingpeoplewheretheyareimplementinghospitalbasedsubstanceuseharmreduction AT appaayesha meetingpeoplewheretheyareimplementinghospitalbasedsubstanceuseharmreduction AT giulianoro meetingpeoplewheretheyareimplementinghospitalbasedsubstanceuseharmreduction AT hoffmanrobert meetingpeoplewheretheyareimplementinghospitalbasedsubstanceuseharmreduction AT lumpaula meetingpeoplewheretheyareimplementinghospitalbasedsubstanceuseharmreduction AT martinmarlene meetingpeoplewheretheyareimplementinghospitalbasedsubstanceuseharmreduction |